None of the patients had respiratory depression, bradycardia, desaturation, or hypotension
Recalls & Warnings February 20, 2025 Maker of Zicam Agrees to Pay $6 Million to Settle Lawsuit Over Claims to Shorten Colds The maker of Zicam Cold Remedy products, Church & Dwight Co., Inc., has agreed to pay up to $6 million to settle a class action lawsuit that charged it with promoting the products to reduce the severity of cold symptoms and reduce the duration of colds without reliable scientific evidence
Conclusions IV and IM administration of 0.05 mg/kg of buprenorphine cannot be replaced with SC administration, due to a markedly lower peak serum concentration and bioavailability with this route
If the stopper becomes visibly damaged or starts to core (releasing rubber fragments), stop using the vial regardless of how many days remain
Schizophr Res 2020;222:327-34 Kuo CJ et al
Production of hepatocyte-like cells from human pluripotent stem cells